Synthesis, Characterization, and Structure−Activity Relationships of Amidine-Substituted (Bis)benzylidene-Cycloketone Olefin Isomers as Potent and Selective Factor Xa Inhibitors

This publication has 19 references indexed in Scilit:

• (Z,Z)-2,7-Bis(4-amidinobenzylidene)cycloheptan-1-one: Identification of a Highly Active Inhibitor of Blood Coagulation Factor Xa
  Journal of Medicinal Chemistry, 1998
• Discovery of N-[2-[5-[Amino(imino)methyl]-2-hydroxyphenoxy]-3,5-difluoro- 6-[3-(4,5-dihydro-1-methyl-1H-imidazol-2-yl)phenoxy]pyridin-4-yl]-N-methylglycine (ZK-807834): A Potent, Selective, and Orally Active Inhibitor of the Blood Coagulation Enzyme Factor Xa
  Journal of Medicinal Chemistry, 1998
• Rational Design and Synthesis of Novel, Potent Bis-phenylamidine Carboxylate Factor Xa Inhibitors
  Journal of Medicinal Chemistry, 1998
• Sustained Inhibition of Whole-Blood Clot Procoagulant Activity by Inhibition of Thrombus-Associated Factor Xa
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1996
• Selective inhibition of factor Xa during thrombolytic therapy markedly improves coronary artery patency in a canine model of coronary thrombosis
  Blood Coagulation & Fibrinolysis, 1996
• Role of Thrombin Compared With Factor Xa in the Procoagulant Activity of Whole Blood Clots
  Circulation, 1995
• Antithrombotic Effects of Orally Active Synthetic Antagonist of Activated Factor X in Nonhuman Primates
  Circulation, 1995
• Dibasic (Amidinoaryl)propanoic Acid Derivatives as Novel Blood Coagulation Factor Xa Inhibitors
  Journal of Medicinal Chemistry, 1994
• Importance of factor Xa in determining the procoagulant activity of whole-blood clots.
  Journal of Clinical Investigation, 1993
• Acceleration of recombinant tissue-type plasminogen activator-induced reperfusion and prevention of reocclusion by recombinant antistasin, a selective factor Xa inhibitor, in a canine model of femoral arterial thrombosis.
  Circulation Research, 1992